System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Marc Righini is an expert in Hematology at University Hospital of Geneva (Switzerland). As of October 2026, ScienceLeadR ranks Marc Righini in the top 1% of experts worldwide for Pulmonary Embolism and Embolism and Thrombosis. Marc Righini has authored 490 publications, the most recent in 2026, and is an investigator in 37 clinical trials, 4 of them ongoing. SLR score: 1,845 (community average: 125). How the SLR is computed.

LeadR Profile

Marc Righini University Hospital of Geneva Switzerland
1 845 ScienceLeadR Reputation 1845

Unlock

Register Login
Network Map

Hematology

Subspecialties: Cardiology - Public Health - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026
Source: PubMed

University Hospital of Geneva

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 490

Citations

Citations: 28 253 1st author: 68 Last author: 103 Unique author: 8

Main journals

J Thromb Haemost 82
Rev Med Suisse 53
Thromb Haemost 32
Thromb Res 29
Revue Médicale Suisse 21

Best Journals

JAMA 9
N Engl J Med 7
Ann Intern Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Reported items and methods for analysis in diagnostic management studies evaluating venous thromboembolism: a systematic review: Communication from the ISTH SSC Subcommittee on Diagnosis and Prediction in Thrombotic Disease.
PMID 42892332 — thromboembolism, communication, pulmonary embolism, diagnosis, venous thromboembolism, thrombosis		J Thromb Haemost20260
Factors Associated With Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis.
PMID 42886105 — thromboembolism, neoplasms, therapeutics, venous thromboembolism, thrombosis, apixaban		JACC CardioOncol20260
Lower extremity amputations in Switzerland: Trends in patients with and without diabetes, 2013-2023.
PMID 42656925 — diabetes mellitus, mortality, hospital mortality, amputation, surgical		Int J Cardiol Cardiovasc Risk Prev20260
Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.
PMID 42459131 — anticoagulants, thromboembolism, hemorrhage, incidence, intracranial hemorrhages, therapeutics, venous thromboembolism		Haematologica20260
Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS project.
PMID 42447897 — anticoagulants, thromboembolism, hemorrhage, decision making, shared, decision making, biomarkers, therapeutics, venous thromboembolism, thrombosis, prognosis, hemostasis		Thromb Haemost20260

Clinical Studies 37

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 10

By phase:

N/A 18
Phase 3 13
Phase 4 5
Phase 2 1

By status:

Completed 24
Recruiting 4
Unknown 4
Terminated 3
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 26
Observational 11

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 3
multicentric5to9 8
multicentricup10 18

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Early Exercise Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
NCT07143539 — depression, exercise, physical therapists, quality of life, exercise tolerance, thromboembolism, rehabilitation centers, embolism, safety, exercise therapy, venous thrombosis, rehabilitation, signs and symptoms, pulmonary embolism, anxiety disorders, diagnosis, therapeutics, venous thromboembolism, resistance training, thrombosis, dyspnea, outpatients, education, veins, functional status		N/ARecruiting2025
The API CALF Study Apixaban to Treat Calf Vein Thrombosis
NCT04981327 — anticoagulants, venous thrombosis, tablets, therapeutics, thrombosis, veins, direct-acting oral anticoagulants, apixaban		Phase 3Not yet recruiting2022
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159 — mortality, stroke, myocardial infarction, colchicine, pharmaceutical preparations, tablets, arteries, atherosclerosis, peripheral arterial disease, therapeutics, ischemia		Phase 3Recruiting2021
Pulmonary Embolism International THrOmbolysis Study 3
NCT04430569 — embolism, plasminogen, plasminogen activators, tissue plasminogen activator, pulmonary embolism, therapeutics, tissues, infusions, intravenous		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS